Available and affordable complementary treatments for COVID-19 : From hypothesis to pilot studies and the need for implementation

Show full item record



Permalink

http://hdl.handle.net/10138/343030

Citation

Bousquet , J , Haahtela , T , Blain , H , Czarlewski , W , Zuberbier , T , Bedbrook , A , Cruz , A A , Fonseca , J A , Klimek , L , Kuna , P , Samolinski , B , Valiulis , A , Lemaire , A & Anto , J M 2022 , ' Available and affordable complementary treatments for COVID-19 : From hypothesis to pilot studies and the need for implementation ' , Clinical and Translational Allergy , vol. 12 , no. 3 , 12127 . https://doi.org/10.1002/clt2.12127

Title: Available and affordable complementary treatments for COVID-19 : From hypothesis to pilot studies and the need for implementation
Author: Bousquet, Jean; Haahtela, Tari; Blain, Hubert; Czarlewski, Wienczyslawa; Zuberbier, Torsten; Bedbrook, Anna; Cruz, Alvaro A.; Fonseca, Joao A.; Klimek, Ludger; Kuna, Piotr; Samolinski, Boleslaw; Valiulis, Arunas; Lemaire, Antoine; Anto, Josep M.
Contributor organization: HUS Inflammation Center
Department of Dermatology, Allergology and Venereology
University of Helsinki
Date: 2022-03
Language: eng
Number of pages: 7
Belongs to series: Clinical and Translational Allergy
ISSN: 2045-7022
DOI: https://doi.org/10.1002/clt2.12127
URI: http://hdl.handle.net/10138/343030
Abstract: Vaccination is a highly effective preventive measure against COVID-19. However, complementary treatments are needed to better control the disease. Fermented vegetables and spices, agonists of the antioxidant transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and TRPA1/V1 channels (Transient Receptor Potential Ankyrin 1 and Vanillin 1), may help in the control of COVID-19. Some preliminary clinical trials suggest that curcumin (spice) can prevent some of the COVID-19 symptoms. Before any conclusion can be drawn and these treatments recommended for COVID-19, the data warrant confirmation. In particular, the benefits of the foods need to be assessed in more patients, through research studies and large trials employing a double-blind, placebo-controlled design.
Subject: broccoli
COVID-19
curcumin
Nrf2
TRP channel
DESENSITIZATION
CURCUMIN
STRATEGY
3121 General medicine, internal medicine and other clinical medicine
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
Clinical_Transl ... ents_for_COVID_19_From.pdf 450.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record